Squarepoint Ops LLC Bicycle Therapeutics PLC Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$12.95 - $46.99 $151,515 - $549,783	-11,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$40.12 - $59.5 $140,420 - $208,250	3,500 Added 42.68%	11,700 $513,000
Q4 2021 Feb 14, 2022	BUY	$41.7 - $61.14 $341,940 - $501,348	8,200 New	8,200 $499,000
Q3 2020 Nov 16, 2020	SELL	$15.3 - $20.8 $158,661 - $215,696	-10,370 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$12.63 - $18.21 $34,580 - $49,858	-2,738 Reduced 20.89%	10,370 $163,000
Q1 2020 May 15, 2020	BUY	$9.82 - $18.0 $128,720 - $235,944	13,108 New	13,108 $179,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $433M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.